In this article, we will discuss Palonosetron Clinical Trials Effect (Cardiovascular). So, let’s get started.
Palonosetron Clinical Trials Effect (Cardiovascular)
1%: non-sustained tachycardia, bradycardia, hypotension, < 1%: hypertension, myocardial ischemia, extrasystoles, sinus tachycardia, sinus arrhythmia, supraventricular extrasystoles and QT prolongation. In many cases, the relationship to palonosetron was unclear.